Market watch: 2017 FDA drug approvals: number rebounds but average value slips

Nature Reviews Drug Discovery 17, 87 (2018). doi:10.1038/nrd.2018.2 Authors: Mathias Baedeker, Michael Ringel, Valery Panier & Ulrik Schulze In line with our outlook last year (Nat Rev. Drug Discov.16, 78; 2017), there was a rebound in the number of new drugs approved by the FDA in 2017 compared with 2016 (Nat. Rev. Drug Discov. 17, 81–85;
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research